ArticleCureus2025
Evaluating Laser Haemorrhoidoplasty as a Short-Term Approach to Advanced Haemorrhoidal Disease.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Haemorrhoids are a benign anorectal condition that can significantly impact the quality of life of patients. Well-established treatments for advanced haemorrhoidal disease are not without complications. Laser haemorrhoidoplasty (LHP) is a less invasive non-excisional surgical technique that has fewer complications than conventional management. Methodology A retrospective study of all patients who received LHP for symptomatic Grade 3 and Grade 4 haemorrhoids from November 2017 to March 2022 in a district general hospital was conducted to assess short-term functional outcomes. Patients were asked to report the severity of pain on the Visual Analogue Scale and frequency of symptoms based on the Haemorrhoidal Severity Score (HSS developed by Nyström) two months before and after LHP. Participant consent and feedback were obtained either by a written questionnaire or a phone interview. Results A total of 57 patients were interviewed. The most common symptoms were bleeding (n = 54), prolapse needing reduction (n = 45), pain (n = 43), itching and discomfort (n = 28), and soiling (n = 24). There was a significant improvement in the severity of pain (p < 0.0001) postoperatively. Patients reported an improvement of their pre-existing symptoms, including pain (p < 0.00001), itching and discomfort (p = 0.0001), bleeding (p < 0.00001), soiling (p = 0.00007), and prolapse (p < 0.00001) based on HSS. Conclusions Evidence from this study suggests that LHP provides significant short-term improvement in the severity of symptoms for patients with symptomatic third- and fourth-degree haemorrhoids. While the results of this study are encouraging, larger prospective multicentre studies assessing long-term outcomes will be desirable for proper evaluation of LHP with respect to its efficacy and cost-effectiveness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.